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IMPACT OF NITRIC OXIDE INHALATION ON RIGHT VENTRICULAR FAILURE AFTER 
IMPLANTATION OF NOVACOR LEFT VENTRICULAR ASSIST SYSTEM 
Paul Michel Mertes, MD, Georges Pinelli, MD, Thierry Hubert, MD, Jean Pierre Carteaux, MD, 
Etienne Hottier, MD, Alain Larcan, MD, and Jean Pierre Villemot, MD, Nancy, France 
The left ventricular assist system (LVAS) (Baxter Health- 
care Corporation, Novacor Division, Oakland, Calif.) used 
as a bridge in the expectation of transplantation has been 
shown to effectively improve cardiac output even in patients 
with biventricular failure) Nevertheless, many patients till 
require some sort of inotropic support and/or pulmonary 
vasodilator therapy to optimize right ventricular (RV) per- 
formance. Consequently, appropriate selection of potential 
recipients calls for careful evaluation of preimplantation 
pulmonary artery pressure and vascular esistance, which 
should remain in a suitable range to ensure successful heart 
transplantation. However, in certain cases, high pulmonary 
resistance necessitating concomitant RV support has been 
observed. We report here one such case in which an early 
rise in pulmonary artery pressure led to rapid RV failure, 
and the use of inhaled nitric oxide allowed us to forgo the 
need for mechanical RV support. 
A 54-year-old man with dilated idiopathic ardiomyop- 
athy received an LVAS because of repeated episodes of 
left ventricular failure necessitating i creasing doses of 
sympathomimetic drugs. This patient was regarded eligi- 
ble for heart ransplantation. The preoperative pulmonary 
vascular resistance was 4 Wood units. After he was 
weaned from cardiopulmonary b pass (CPB), a rapid rise 
in mean pulmonary arterial pressure was observed from 
40 to 65 mm Hg, associated with a decrease in RV ejection 
fraction from 17% to 6% and persistent low pump output 
below 3 L/rain. This reduced pump output was related to 
difficulties in pump filling as witnessed by the reduction in 
LVAS peak filling volume, which precisely monitors this 
phenomenon. This change occurred despite the use of 
isoproterenol (0.1 ~g/kg per minute) and epinephrine (0.2 
p~g/kg per minute) therapy, concomitant with administra- 
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tion of prostacyclin at an increasing rate of 5 to 20 ng/kg 
per minute. After an hour, in the absence of a satisfactory 
hemodynamic response, CPB was reinstituted. Nitric ox- 
ide was then administered as a specific pulmonary vaso- 
dilator therapy in a premixed concentration of 900 ppm 
nitric oxide in nitrogen (CFPO, Paris, France). Nitric 
oxide was introduced into the breathing system circuit 
near the endotracheal tube via a separate flowmeter. The 
nitric oxide flow rate was adjusted to reach a concentra- 
tion of 50 ppm. Almost 30 minutes later, a progressive 
increase in peak LVAS filling volume was noted. CPB was 
then progressively interrupted. At the same time, LVAS 
pump output rapidly increased to 5 L/min, RV function 
improved (ejection fraction 17%), and mean pulmonary 
arterial pressure dropped to 35 mm Hg. The day after, mean 
pulmonary arterial pressure further decreased to 27 mm Hg 
while RV ejection fraction rose to 23%. Inotropic support 
and nitric oxide inhalation were then progressively decreased 
and the patient was extubated after 5 days. 
This observation underscores the possibility afforded by 
nitric oxide inhalation in the reduction of acutely in- 
creased pulmonary vascular esistance after CPB during 
LVAS implantation. 2'3 In our opinion, its feasibility 
should be considered before any decision is made to 
institute RV support in cases of early inadequate LVAS 
system filling. 
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